First prospective data on breast cancer patients from the multicentre italian bone metastasis database

Abstract Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-related events (SREs) that reduce quality of life. They have also led to increased social and healthcare costs. At present, data available on BM are insufficient. This was a multicentre prospec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alberto Bongiovanni, Flavia Foca, Manuela Fantini, Maria Rosachiara Forcignanò, Fabrizio Artioli, Rossana Berardi, Enrico Campadelli, Giuseppe Procopio, Francesco Silvestris, Nada Riva, Lorena Gurrieri, Silvia Angela Debonis, Giandomenico Di Menna, Valentina Fausti, Federica Recine, Roberto Vespignani, Toni Ibrahim
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/693a0fc1e87149f99ffcaa4f3dfc147a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:693a0fc1e87149f99ffcaa4f3dfc147a
record_format dspace
spelling oai:doaj.org-article:693a0fc1e87149f99ffcaa4f3dfc147a2021-12-02T14:28:18ZFirst prospective data on breast cancer patients from the multicentre italian bone metastasis database10.1038/s41598-021-83749-12045-2322https://doaj.org/article/693a0fc1e87149f99ffcaa4f3dfc147a2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83749-1https://doaj.org/toc/2045-2322Abstract Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-related events (SREs) that reduce quality of life. They have also led to increased social and healthcare costs. At present, data available on BM are insufficient. This was a multicentre prospective observational study of patients with BM from breast cancer (BC) with at least 6 months’ follow-up. Information on patients at the first diagnosis of BM, including demographics and characteristics of the primary tumor and BM. Data were periodically updated by participating centres and reviewed by the coordinator centre. From October 2014 to July 2019, 618 patients with BM from solid tumors were enrolled and 220 were eligible for the present study. Median age was 62 years (range 26–86). Median follow-up was 34 months (range 6–149). At the time of enrolment, 109 (50%) had only BM (BOM) and 109 (50%) had concomitant visceral lesions and BM (BVM). Median time-to-first BM was 47 months (range 0–312) in BOM and 78.6 months in BVM patients. Disease-free interval differed on the basis of BC molecular subtype and stage. Ninety-eight BM patients had at least on SRE. Zoledronate was used in 69.1% of cases and denosumab in 28.3%. First-line treatment was hormone-based (50.7%), chemotherapy-based (38.7%) or chemotherapy- + hormone therapy-based (9.7%). Median progression-free and overall survival were 15.1 months (95% CI 12.6–18.4) and 66.8 months (95% CI 52.1–79.2), respectively. Our prospective study could substantially help to better understand the natural history of BM from BC.Alberto BongiovanniFlavia FocaManuela FantiniMaria Rosachiara ForcignanòFabrizio ArtioliRossana BerardiEnrico CampadelliGiuseppe ProcopioFrancesco SilvestrisNada RivaLorena GurrieriSilvia Angela DebonisGiandomenico Di MennaValentina FaustiFederica RecineRoberto VespignaniToni IbrahimNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Alberto Bongiovanni
Flavia Foca
Manuela Fantini
Maria Rosachiara Forcignanò
Fabrizio Artioli
Rossana Berardi
Enrico Campadelli
Giuseppe Procopio
Francesco Silvestris
Nada Riva
Lorena Gurrieri
Silvia Angela Debonis
Giandomenico Di Menna
Valentina Fausti
Federica Recine
Roberto Vespignani
Toni Ibrahim
First prospective data on breast cancer patients from the multicentre italian bone metastasis database
description Abstract Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-related events (SREs) that reduce quality of life. They have also led to increased social and healthcare costs. At present, data available on BM are insufficient. This was a multicentre prospective observational study of patients with BM from breast cancer (BC) with at least 6 months’ follow-up. Information on patients at the first diagnosis of BM, including demographics and characteristics of the primary tumor and BM. Data were periodically updated by participating centres and reviewed by the coordinator centre. From October 2014 to July 2019, 618 patients with BM from solid tumors were enrolled and 220 were eligible for the present study. Median age was 62 years (range 26–86). Median follow-up was 34 months (range 6–149). At the time of enrolment, 109 (50%) had only BM (BOM) and 109 (50%) had concomitant visceral lesions and BM (BVM). Median time-to-first BM was 47 months (range 0–312) in BOM and 78.6 months in BVM patients. Disease-free interval differed on the basis of BC molecular subtype and stage. Ninety-eight BM patients had at least on SRE. Zoledronate was used in 69.1% of cases and denosumab in 28.3%. First-line treatment was hormone-based (50.7%), chemotherapy-based (38.7%) or chemotherapy- + hormone therapy-based (9.7%). Median progression-free and overall survival were 15.1 months (95% CI 12.6–18.4) and 66.8 months (95% CI 52.1–79.2), respectively. Our prospective study could substantially help to better understand the natural history of BM from BC.
format article
author Alberto Bongiovanni
Flavia Foca
Manuela Fantini
Maria Rosachiara Forcignanò
Fabrizio Artioli
Rossana Berardi
Enrico Campadelli
Giuseppe Procopio
Francesco Silvestris
Nada Riva
Lorena Gurrieri
Silvia Angela Debonis
Giandomenico Di Menna
Valentina Fausti
Federica Recine
Roberto Vespignani
Toni Ibrahim
author_facet Alberto Bongiovanni
Flavia Foca
Manuela Fantini
Maria Rosachiara Forcignanò
Fabrizio Artioli
Rossana Berardi
Enrico Campadelli
Giuseppe Procopio
Francesco Silvestris
Nada Riva
Lorena Gurrieri
Silvia Angela Debonis
Giandomenico Di Menna
Valentina Fausti
Federica Recine
Roberto Vespignani
Toni Ibrahim
author_sort Alberto Bongiovanni
title First prospective data on breast cancer patients from the multicentre italian bone metastasis database
title_short First prospective data on breast cancer patients from the multicentre italian bone metastasis database
title_full First prospective data on breast cancer patients from the multicentre italian bone metastasis database
title_fullStr First prospective data on breast cancer patients from the multicentre italian bone metastasis database
title_full_unstemmed First prospective data on breast cancer patients from the multicentre italian bone metastasis database
title_sort first prospective data on breast cancer patients from the multicentre italian bone metastasis database
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/693a0fc1e87149f99ffcaa4f3dfc147a
work_keys_str_mv AT albertobongiovanni firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT flaviafoca firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT manuelafantini firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT mariarosachiaraforcignano firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT fabrizioartioli firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT rossanaberardi firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT enricocampadelli firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT giuseppeprocopio firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT francescosilvestris firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT nadariva firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT lorenagurrieri firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT silviaangeladebonis firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT giandomenicodimenna firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT valentinafausti firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT federicarecine firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT robertovespignani firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
AT toniibrahim firstprospectivedataonbreastcancerpatientsfromthemulticentreitalianbonemetastasisdatabase
_version_ 1718391257442549760